Skip to content

Gastric condition assessment test: Pivotal study

Gastric condition assessment test: Pivotal study - -

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1070260016
Enrollment
16
Registered
2026-04-23
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer -

Interventions

- Administration of acetaminophen to evaluate gastric emptying rate - Administration of rabeprazole sodium to create a low gastric acid state - Local anesthesia and catheter insertion for use during c
Acetaminophen, rabeprazole, local anesthetic, catheter

Sponsors

Sawada Toyohiro
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Healthy Japanese adult males aged 18 to 45 years at the time of consent Subjects weighing 50 to 80 kg Subjects with a BMI of 18.5 to 25.0 (rounded down to one decimal place)

Exclusion criteria

Exclusion criteria: Persons with a history of major gastrointestinal surgery, such as gastrectomy, gastrointestinal suture, or intestinal resection (appendectomy and inguinal hernia repair are acceptable). Persons with a history of serious illnesses, such as cerebrovascular disease, thromboembolism, ischemic heart disease, autoimmune disease, or convulsive disorders (including epilepsy). Persons with drug hypersensitivity or allergies. Alcohol or drug addicts.

Design outcomes

Primary

MeasureTime frame
Gastric emptying rate, gastric content evaluation (gastric pH, etc.), total gastric content volume evaluation, etc.

Contacts

Public ContactTomohisa Kato

Sawai Pharmaceutical Co., Ltd.

t.kato@sawai.co.jp+81-9090599454

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026